Join
Live feed
·
INSIDERFilingvia Quantisnow
Opus Genetics Inc. logo

Director Foundation Fighting Blindness Retinal Degeneration Fund converted options into 6,927,419 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
IRD· Opus Genetics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IRD (Opus Genetics Inc.) and more on Quantisnow.